gastrointestinal tumors

photo of a green light on a stoplight

FDA adds uses for Merck's Keytruda, Pfizer and Astellas' Xtandi

The FDA has signed off on label expansions for two of the world’s most important cancer medicines—Merck’s Keytruda and Pfizer and Astellas’ Xtandi.

Kevin Dunleavy Nov 17, 2023 11:18am

bowel

Evonik signs on to manufacture Phathom's GI treatment

Oct 11, 2022 9:35am

Imfinzi

AstraZeneca's Imfinzi snags an I-O first before key FDA verdicts

Sep 6, 2022 11:22am